BMO Capital raises LyondellBasell stock price target on earnings tailwinds By Investing.com

BMO Capital raised LyondellBasell’s price target to $88 while keeping a Market Perform rating, citing near-term earnings tailwinds from U.S. polyethylene prices, margins, and continued disruption in Middle East petrochemical supply. The firm expects additional support from intermediates, derivatives, oxyfuels, and cost reductions, with supply chain normalization unlikely this year. The stock is already up 76% over the past six months and recently reported Q1 EPS of $0.49 versus $0.24 consensus, despite revenue of $7.2B missing estimates.

Analysis

LYB is a cleaner beneficiary of a Middle East supply shock than the market is pricing because its earnings delta comes from both price and operating leverage, not just volume. The important second-order effect is that a disruption in global petrochemical flows tightens U.S. resin export economics while simultaneously lowering the odds of a quick inventory rebuild, which can keep domestic PE spreads firm even after headline oil volatility fades. That makes the setup more durable over the next 1-2 quarters than a simple one-day energy beta trade.

The risk is that the market is likely extrapolating the current margin spike too far out the curve. If crude stays elevated but naphtha/feedstock costs catch up faster than finished PE prices, LYB's downstream margin benefit can compress just as consensus upgrades peak; historically, these chemical rallies are most vulnerable when product pricing lags crude by 4-8 weeks. A second reversal catalyst is any evidence that shipping lanes normalize, because the equity is already discounting a prolonged supply dislocation.

The broader winner set is U.S. exporters and integrated names with advantaged feedstock, while the hidden losers are packaging, consumer durables, and lower-quality chemical peers without balance sheet flexibility. The market may also be underappreciating that a sustained PE rebound can eventually pull forward restarts and imports, capping upside beyond the next quarter. In other words, the trade is attractive now, but the cleanest alpha window is before the first round of earnings revisions fully catches up.

Contrarian view: this is less a structural re-rating of chemical fundamentals than a tactical spread trade on geopolitics. If the shock proves transitory, LYB's recent outperformance could unwind quickly because the stock has already re-rated on the assumption of persistent earnings upgrades. The best risk/reward is to own it through the next earnings revision cycle, not to chase it once the market starts treating the margin move as permanent.

Key Decisions for Investors

• Go long LYB for the next 4-8 weeks into the next estimate revision cycle; target a move toward the mid/high-$80s if PE spreads hold, but trim if crude stays elevated while resin prices flatten.
• Pair trade: long LYB / short a weaker North American chemical peer with less pricing power and higher feedstock sensitivity over the next quarter; thesis is spread capture plus relative multiple expansion for the advantaged operator.
• Sell downside puts in LYB one expiry out-of-the-money for the next earnings window if implied volatility remains elevated; collect premium while the market is still pricing geopolitical headline risk.
• For a cleaner macro hedge, consider a small short in a packaging or resin-intensive industrial beneficiary of lower input-cost certainty; if PE costs stay sticky, those margins should lag within 1-2 quarters.
• Take profits into any further strength above the current analyst target band; the asymmetry worsens once the market has fully capitalized the near-term earnings boost and the trade becomes dependent on a sustained disruption.